The adverse effects of eotaxin, OPG and TNFRSF9 on NAFLD development underscore the potential role of these inflammatory markers in the pathophysiology of hepatic steatosis. Here, CCL11 is linked to metabolic dysfunction-associated steatotic liver disease.